Related Experiment Videos

p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes

E Roper1, W Weinberg, F M Watt

  • 1Imperial Cancer Research Fund, London, UK.

EMBO Reports
|March 22, 2001
PubMed

Insights

Activated Ras in skin cancer co-operates with p53 inactivation. Raf pathway activation causes cell cycle arrest dependent on p53 and p21Cip1, but not p19ARF, revealing multiple oncogene mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Activated Ras collaborates with p53 mutations in skin tumorigenesis.
  • The molecular mechanisms underlying this cooperation are not fully understood.

Purpose of the Study:

  • To investigate the role of the Raf/MAP kinase pathway in skin cell proliferation and differentiation.
  • To elucidate the involvement of p53, p21Cip1, and p19ARF in Raf-mediated cellular responses.

Main Methods:

  • Primary mouse keratinocyte culture.
  • Analysis of cell cycle arrest and differentiation markers.
  • Gene knockout studies (p53, p21Cip1, p19ARF).

Main Results:

  • Raf activation in keratinocytes induced p53 and p21Cip1-dependent cell cycle arrest and differentiation.
  • Loss of p53 or p21Cip1 function abrogated Raf-induced growth inhibition but not differentiation.
  • p19ARF was not essential for Raf-induced p53 activation and cell cycle arrest.

Conclusions:

  • p53 and p21Cip1 are crucial for inhibiting proliferation in response to Raf pathway activation.
  • Loss of p53 or p21Cip1 function is necessary to bypass Raf-induced growth arrest.
  • Oncogenes utilize multiple pathways to activate p53, independent of p19ARF in keratinocytes.

Related Concept Videos